De Biasi, M., McLaughlin, I., Perez, E., Crooks, P., Dwoskin, L., Bardo, M., … Hatsukami, D. (2014). Scientific overview: 2013 BBC plenary symposium on tobacco addiction. Drug and Alcohol Dependence, 141, 107-17. https://doi.org/10.1016/j.drugalcdep.2014.05.013 (Original work published 2014)

Harrod, S., Dwoskin, L., Crooks, P., Klebaur, J., & Bardo, M. (2001). Lobeline attenuates d-methamphetamine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics, 298(1), 172-9. Retrieved from https://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=11408539

Green, T., Phillips, S., Crooks, P., Dwoskin, L., & Bardo, M. (2000). Nornicotine pretreatment decreases intravenous nicotine self-administration in rats. Psychopharmacology, 152(3), 289-94. https://doi.org/10.1007/s002130000524

Bardo, M., Green, T., Crooks, P., & Dwoskin, L. (1999). Nornicotine is self-administered intravenously by rats. Psychopharmacology, 146(3), 290-6. https://doi.org/10.1007/s002130051119

Dwoskin, L., Crooks, P., Teng, L., Green, T., & Bardo, M. (1999). Acute and chronic effects of nornicotine on locomotor activity in rats: altered response to nicotine. Psychopharmacology, 145(4), 442-51. https://doi.org/10.1007/s002130051079

Bardo, M., Bevins, R., Klebaur, J., Crooks, P., & Dwoskin, L. (1997). (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats. Pharmacology, Biochemistry, and Behavior, 58(4), 1083-7. https://doi.org/10.1016/s0091-3057(97)00303-1

Meyer, A., Neugebauer, N., Zheng, G., Crooks, P., Dwoskin, L., & Bardo, M. (2013). Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Journal of Neurochemistry, 127(2), 187-98. https://doi.org/10.1111/jnc.12373

Wilmouth, C., Zheng, G., Crooks, P., Dwoskin, L., & Bardo, M. (2013). Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats. Pharmacology, Biochemistry, and Behavior, 112, 29-33. https://doi.org/10.1016/j.pbb.2013.09.006

Crooks, P., Bardo, M., & Dwoskin, L. Nicotinic receptor antagonists as treatments for nicotine abuse. Advances in Pharmacology (San Diego, Calif.), 69, 513-51. https://doi.org/10.1016/B978-0-12-420118-7.00013-5 (Original work published 2014)

Houdi, A., Kottayil, S., Crooks, P., & Butterfield, D. (1996). 3-O-acetylmorphine-6-O-sulfate: a potent, centrally acting morphine derivative. Pharmacology, Biochemistry, and Behavior, 53(3), 665-71. https://doi.org/10.1016/0091-3057(95)02067-5